Handelsbanken Fonder’s ADMA Biologics ADMA Stock Holding History

Handelsbanken Fonder’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$827K	Buy	98,800 +21,000	+27%	+$191K	﹤0.01%	1220
2026 Q1	$701K	Hold	77,800	–	–	﹤0.01%	1191
2025 Q4	$1.42M	Buy	77,800 +12,200	+19%	+$206K	﹤0.01%	882
2025 Q3	$962K	Hold	65,600	–	–	﹤0.01%	1020
2025 Q2	$1.2M	Sell	65,600 -100	-0.2%	-$2.04K	﹤0.01%	880
2025 Q1	$1.3M	Hold	65,700	–	–	0.01%	832
2024 Q4	$1.13M	Buy	+65,700	New	+$1.24M	﹤0.01%	918

Other funds holding ADMA

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MCM

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Handelsbanken Fonder's ADMA Position: Q2 2026 in Review

Handelsbanken Fonder increased its ADMA Biologics (ADMA) stake by 27% in Q2 2026, buying an estimated $191K and bringing the position to 98,800 shares worth $827K. The position accounts for ﹤0.01% of the portfolio, ranked #1220.

Handelsbanken Fonder first reported a position in ADMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.42M in Q4 2025. 81 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Handelsbanken Fonder held 98,800 shares of ADMA Biologics worth $827K as of Q2 2026.
Handelsbanken Fonder bought 21,000 ADMA Biologics shares in Q2 2026, an estimated $191K.
ADMA Biologics made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1220 holding.
Handelsbanken Fonder first reported a position in ADMA Biologics in Q4 2024 and has held it in 7 quarters since.
Handelsbanken Fonder's ADMA Biologics position peaked at $1.42M in Q4 2025.
81 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.